Reply to: "Acute liver failure due to immune-mediated hepatitis successfully managed with plasma exchange: New settings call for new treatment strategies?"

Affiliations

¹ AP-HP Hôpital Paul Brousse, Centre Hépato-Biliaire, Univ Paris-Sud, UMR-S 1193, Université Paris-Saclay Villejuif, DHU Hepatinov, France.
² Département d'innovation thérapeutique et d'Essais Précoces (DITEP), Institut Gustave-Roussy, Université Paris-Saclay, Villejuif, France.
³ AP-HP Hôpital Bicêtre, Department of Pathology, Le Kremlin-Bicêtre, France; Univ Paris-Sud, UMR-S 1193, Université Paris-Saclay, France.
⁴ APHP Hôpital Bicêtre, Service de Médecine Interne et Immunologie Clinique, Université Paris-Sud, CEA, DSV/iMETI, Division of Immunovirology, IDMIT, INSERM, U1184, Center for Immunology of Viral Infections and Autoimmune Diseases, Le Kremlin-Bicêtre, France.
⁵ Dermatology Unit, Department of Medical Oncology, Gustave Roussy, Paris-Sud University, Villejuif, France.
⁶ AP-HP Hôpital Bicêtre, Department of Pathology, Le Kremlin-Bicêtre, France.
⁷ AP-HP Hôpital Paul Brousse, Centre Hépato-Biliaire, Univ Paris-Sud, UMR-S 1193, Université Paris-Saclay Villejuif, DHU Hepatinov, France. Electronic address: didier.samuel@aphp.fr.

Comment

Eleonora De Martin et al. J Hepatol. 2019 Mar.

. 2019 Mar;70(3):566-567.

doi: 10.1016/j.jhep.2018.11.016. Epub 2018 Dec 5.

¹ AP-HP Hôpital Paul Brousse, Centre Hépato-Biliaire, Univ Paris-Sud, UMR-S 1193, Université Paris-Saclay Villejuif, DHU Hepatinov, France.
² Département d'innovation thérapeutique et d'Essais Précoces (DITEP), Institut Gustave-Roussy, Université Paris-Saclay, Villejuif, France.
³ AP-HP Hôpital Bicêtre, Department of Pathology, Le Kremlin-Bicêtre, France; Univ Paris-Sud, UMR-S 1193, Université Paris-Saclay, France.
⁴ APHP Hôpital Bicêtre, Service de Médecine Interne et Immunologie Clinique, Université Paris-Sud, CEA, DSV/iMETI, Division of Immunovirology, IDMIT, INSERM, U1184, Center for Immunology of Viral Infections and Autoimmune Diseases, Le Kremlin-Bicêtre, France.
⁵ Dermatology Unit, Department of Medical Oncology, Gustave Roussy, Paris-Sud University, Villejuif, France.
⁶ AP-HP Hôpital Bicêtre, Department of Pathology, Le Kremlin-Bicêtre, France.
⁷ AP-HP Hôpital Paul Brousse, Centre Hépato-Biliaire, Univ Paris-Sud, UMR-S 1193, Université Paris-Saclay Villejuif, DHU Hepatinov, France. Electronic address: didier.samuel@aphp.fr.

No abstract available

Comment on

Characterization of liver injury induced by cancer immunotherapy using immune checkpoint inhibitors.
De Martin E, Michot JM, Papouin B, Champiat S, Mateus C, Lambotte O, Roche B, Antonini TM, Coilly A, Laghouati S, Robert C, Marabelle A, Guettier C, Samuel D. De Martin E, et al. J Hepatol. 2018 Jun;68(6):1181-1190. doi: 10.1016/j.jhep.2018.01.033. Epub 2018 Feb 8. J Hepatol. 2018. PMID: 29427729
Acute liver failure due to immune-mediated hepatitis successfully managed with plasma exchange: New settings call for new treatment strategies?
Riveiro-Barciela M, Muñoz-Couselo E, Fernandez-Sojo J, Diaz-Mejia N, Parra-López R, Buti M. Riveiro-Barciela M, et al. J Hepatol. 2019 Mar;70(3):564-566. doi: 10.1016/j.jhep.2018.10.020. Epub 2018 Nov 28. J Hepatol. 2019. PMID: 30503040 No abstract available.